TECELRA Trademark

Trademark Overview


On Thursday, January 7, 2021, a trademark application was filed for TECELRA with the United States Patent and Trademark Office. The USPTO has given the TECELRA trademark a serial number of 90452726. The federal status of this trademark filing is REGISTERED as of Tuesday, August 23, 2022. This trademark is owned by Adaptimmune Limited. The TECELRA trademark is filed in the Pharmaceutical Products and Medical & Beauty Services & Agricultural Services categories with the following description:

Cell therapy pharmaceutical preparations; immunotherapy preparations; T-cell receptors; immunotherapy preparations comprising engineered T-cell Cell therapy pharmaceutical preparations for use in cancer treatment; pharmaceutical immunotherapy preparations for use in cancer treatment; T-cell receptors, namely, pharmaceutical preparations for use in cancer treatment; pharmaceutical immunotherapy preparations comprising engineered T-cell receptors for use in cancer treatment; pharmaceutical immunotherapy preparations comprising genes encoding engineered T-cell receptors for use in cancer treatment

Cell therapy medical treatment services; Medical services, namely, immunotherapy services; Medical services, namely, medical treatment and immune-therapy comprising harvesting a patient's white blood cells, combining white blood cells with an engineered T-cell receptor therapeutic, transducing the white blood cells with the gene encoding the engineered T-cell receptor and infusion of the transduced white blood cells back into the patient
tecelra

General Information


Serial Number90452726
Word MarkTECELRA
Filing DateThursday, January 7, 2021
Status700 - REGISTERED
Status DateTuesday, August 23, 2022
Registration Number6823692
Registration DateTuesday, August 23, 2022
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 7, 2022

Trademark Statements


Goods and ServicesCell therapy pharmaceutical preparations; immunotherapy preparations; T-cell receptors; immunotherapy preparations comprising engineered T-cell Cell therapy pharmaceutical preparations for use in cancer treatment; pharmaceutical immunotherapy preparations for use in cancer treatment; T-cell receptors, namely, pharmaceutical preparations for use in cancer treatment; pharmaceutical immunotherapy preparations comprising engineered T-cell receptors for use in cancer treatment; pharmaceutical immunotherapy preparations comprising genes encoding engineered T-cell receptors for use in cancer treatment
Goods and ServicesCell therapy medical treatment services; Medical services, namely, immunotherapy services; Medical services, namely, medical treatment and immune-therapy comprising harvesting a patient's white blood cells, combining white blood cells with an engineered T-cell receptor therapeutic, transducing the white blood cells with the gene encoding the engineered T-cell receptor and infusion of the transduced white blood cells back into the patient

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, April 6, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, April 6, 2021
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameUSWM CT, LLC
Party Type31 - New Owner After Registration
Legal Entity Type16 - Limited Liability Company
AddressLOUISVILLE, KY 40241

Party NameAdaptimmune Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressOxford OX144RX
GB

Party NameAdaptimmune Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressOxford OX144RX
GB

Party NameAdaptimmune Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressOxford OX144RX
GB

Trademark Events


Event DateEvent Description
Monday, January 11, 2021NEW APPLICATION ENTERED
Tuesday, April 6, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, July 16, 2021ASSIGNED TO EXAMINER
Monday, July 19, 2021EXAMINERS AMENDMENT -WRITTEN
Monday, July 19, 2021EXAMINERS AMENDMENT E-MAILED
Monday, July 19, 2021NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, July 19, 2021EXAMINER'S AMENDMENT ENTERED
Monday, July 19, 2021SUSPENSION LETTER WRITTEN
Monday, July 19, 2021LETTER OF SUSPENSION E-MAILED
Monday, July 19, 2021NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Tuesday, February 8, 2022TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Tuesday, February 8, 2022ASSIGNED TO LIE
Thursday, February 10, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, February 10, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, March 11, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 30, 2022ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Friday, April 29, 2022ELECTRONIC RECORD REVIEW COMPLETE
Wednesday, May 18, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 7, 2022PUBLISHED FOR OPPOSITION
Tuesday, June 7, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 23, 2022REGISTERED-PRINCIPAL REGISTER
Tuesday, August 23, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Wednesday, September 3, 2025AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Monday, December 8, 2025TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, December 8, 2025APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, December 8, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, December 8, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, December 8, 2025TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
Monday, December 8, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED